1. Home
  2. FBYD vs EBS Comparison

FBYD vs EBS Comparison

Compare FBYD & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FBYD

Falcon's Beyond Global Inc.

HOLD

Current Price

$7.41

Market Cap

339.3M

Sector

N/A

ML Signal

HOLD

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

HOLD

Current Price

$6.82

Market Cap

312.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBYD
EBS
Founded
2021
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
339.3M
312.8M
IPO Year
2023
2006

Fundamental Metrics

Financial Performance
Metric
FBYD
EBS
Price
$7.41
$6.82
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $12.00
AVG Volume (30 Days)
119.9K
★ 1.1M
Earning Date
05-14-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 125.83
EPS
★ 0.04
N/A
Revenue
$14,896,000.00
★ $742,900,000.00
Revenue This Year
N/A
$1.29
Revenue Next Year
N/A
N/A
P/E Ratio
$168.75
★ N/A
Revenue Growth
★ 120.85
N/A
52 Week Low
$3.71
$4.36
52 Week High
$29.02
$14.06

Technical Indicators

Market Signals
Indicator
FBYD
EBS
Relative Strength Index (RSI) 43.70 58.64
Support Level $5.80 $5.50
Resistance Level $8.08 $7.05
Average True Range (ATR) 0.75 0.33
MACD 0.13 0.07
Stochastic Oscillator 52.85 83.55

Price Performance

Historical Comparison
FBYD
EBS

About FBYD Falcon's Beyond Global Inc.

Falcons Beyond Global Inc is a visionary entertainment and technology enterprise. The group designs, develops, engineers, delivers, and commercializes immersive physical and digital experiences for brands, developers, and destination operators world-wide, as well as for its own portfolio of entertainment and technology concepts. The Company has five operating segments: Falcon's Creative Group, Destinations Operations, PDP, Falcon's Beyond Brands, and Falcon's Attractions. It earns the majority of the revenue from Falcon's Creative Group segment.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Share on Social Networks: